ArticleCancer research communications2025

The XPO1 Inhibitor Eltanexor Modulates the Wnt/β-Catenin Signaling Pathway to Reduce Colorectal Cancer Tumorigenesis.

Andrew E Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.